PROVIDER PROFILE · NPI 1023421617
David Marin CostaMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
65
Unique beneficiaries
—
Total services
361
Distinct HCPCS
2
Medicare payment
$36K
Peer benchmark
Total Medicare services vs. 19 Hematopoietic Cell Transplantation and Cellular Therapy providers in TX — below median (cohort median 519).
PRESCRIBING · PART D · 2024
Total Rx claims
29
Beneficiaries
—
Total drug cost
$16K
Distinct drugs
2
Brand share
51.7%
Top prescribed drugs
Valacyclovir Hcl15 claims
Posaconazole14 claims
QUALITY · MIPS · 2024
Final MIPS score
84.3
Quality
70.8
Cost
67.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.39%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where David Marin Costa's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 5 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER | 52 | 888 |
| TARRAND, JEFFREY | 19 | 193 |
| Nina Shah Hematology-Oncology · San Francisco, CA | 11 | 163 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER | 53 | 1,023 |
| Qaiser Bashir Internal Medicine · Houston, TX | 14 | 157 |
| TARRAND, JEFFREY | 13 | 67 |
| John Madewell Diagnostic Radiology · Houston, TX | 13 | 62 |
| Stefan Ciurea Hematology-Oncology · Orange, CA | 11 | 276 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE